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Abstract: Facioscapulohumeral Muscular Dystrophy (FSHD) is one of the most 
prevalent forms of muscular dystrophy. However, because of the unique nature 
of the genetic abnormality underlying the disease, there is currently no widely 
available laboratory model. In order to gain insights into FSHD molecular 
pathology, we developed a xenograft model by transplanting myogenic cells from 
patients with FSHD (4qA contractions) as well as from their unaffected relatives 
into the tibialis anterior muscles of immunodeficient mice. Our findings show that 
muscle xenografts derived from FSHD myogenic cells express Dux4 target 
genes, recapitulating the expression of these disease biomarkers in muscle 
biopsies of FSHD patients. FSHD muscle xenografts provide an animal model for 
investigations of the molecular pathogenesis of FSHD muscles and for drug 
development.  
